About UCSF Search UCSF UCSF Medical Center

News

Genetic Discovery Could Help Guide Doctors' Treatment of Bladder Cancers

Genetic Discovery Could Help Guide Doctors' Treatment of Bladder Cancers

October 16, 2013

A UC San Francisco-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.

Prostate Cancer Research Retreat Encourages Collaborations

Prostate Cancer Research Retreat Encourages Collaborations

October 14, 2013

The annual prostate cancer research retreat provided a lively sampling of the work of many UCSF investigators focused on this disease.

Cell Growth Discovery by UCSF Team Has Implications for Targeting Cancer

Cell Growth Discovery by UCSF Team Has Implications for Targeting Cancer

October 11, 2013

The way cells divide to form new cells — to support growth, to repair damaged tissues, or simply to maintain our healthy adult functioning — is controlled in previously unsuspected ways UC San Francisco researchers have discovered. The findings, they said, may lead to new ways to fight cancer.

Scientist Identifies Triple-Negative Breast Cancer Target for Drug Development

Scientist Identifies Triple-Negative Breast Cancer Target for Drug Development

October 3, 2013

Often deadly "triple-negative" breast cancers might be effectively treated in many cases with a drug that targets a previously unknown vulnerability in the tumors, according to a new UC San Francisco study.

NIH Official Says Spending Cuts Pose Unprecedented Threat to Biomedical Research

NIH Official Says Spending Cuts Pose Unprecedented Threat to Biomedical Research

October 1, 2013

Scientific progress and innovation are speeding along, faster than ever before, but arbitrary spending cuts are posing an unprecedented threat.

UCSF Awarded $20M Federal Grant on Tobacco Regulatory Sciences

UCSF Awarded $20M Federal Grant on Tobacco Regulatory Sciences

September 19, 2013

UC San Francisco will receive a five-year, $20 million grant as part of a first-of-its-kind tobacco science regulatory program by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH).